Lans Holdings Inc (fka LAHO)

[Capitalvaluetrade]

Clarification for LAHO on website

http://lans.holdings/Clarification_LANS_MSSV.pdf

Clarification of Transaction With Meso Numismatics Inc.As part of the overall transaction between Lans HoldingsInc.(Lans) and Meso NumismaticsInc.(MSSV)1.MSSV assumed LansDebt 2.MSSV assumed the LOI with Global Stem Cells Group3.Lans received 1,000 series CC redeemable preferred shares of MSSV whereby the 1,000 sharestogetherare convertibleinto a number of common shares of MSSV equal tothetotal number of shares outstanding of MSSVat time of conversionmultiplied by 0.8, see equation below:CC: 1,000 MSSV series CC preferred sharesSO: Total common shares outstanding of MSSV at time of CC conversionCS: Number of common shares of MSSV issuedfromCC conversionCS = SO x 0.8Management’sintent is for Lans Holdings to retain the series CC preferred shares and not toimmediatelyconvert them into MSSV common sharesat this point in timein order for Lansand therefore its shareholdersto benefit from anypotential future appreciationof MSSV. It is management’s opinion that MSSV,through the acquisition of Global Stem Cells Group, has the potential to create significant value for Lansand its shareholders via the series CC preferred shares stake of MSSV held by Lans. In the event that MSSV gains in value, then that value should be translated onto the preferred series CC shares held by Lans and therefore to Lans and its shareholders as well. At a future date for example,when management deems it appropriate to convert the series CC preferred shares into common sharesof MSSV, management may sellthesecommon sharesfor cash in order to fund Lans operations or distribute thesecommon shares to Lans shareholders, again dependingon what management believes would create the mostvalue for Lans and its shareholders. In the eventfor example where management decided to sell the MSSV common shares to fund Lans operations, then management wouldseek to apply for a relisting of Lans shares.Management will base its decision on what would bring the most value to the company and therefore its shareholders. Management may redeem a portion of the series CC preferred sharesat an earlier datefor cash to be used by Lans for working capitalas it works to create valuefor the company and its shareholders.Management believes that this transaction with MSSV should prove to be beneficial for Lans and its shareholders over time andis confident in the potential value that Global Stem Cells Group(GSCG)couldbring. Management believes that GSCGis very well positioned with its numerous offices all over the world to benefit from the significant growth of the worldwide Stem cell industry. In management’s opinion, GSCG has done a good job of aligning itself with reputable medical professionals around the world and has a unique approach togrowth and expansion in the industry using its subsidiaries that provide education, certification,equipment, reagents and branding to clinicsand medical officesall over the world whodesire to enter into the vast and growing stemcell and regenerative medicineindustry.Please refer to this section of Lans website for any further communications that may be posted from time to time by the company.